1. 65 PD-L1 by RNA next generation sequencing: comparison with PD-L1 IHC 22C3 and association with survival benefit from pembrolizumab with or without chemotherapy in non-small cell lung cancer. (10th December 2020) Authors: Lee, Yong Hee; Dy, Grace; DePietro, Paul; Conroy, Jeffrey; Pabla, Sarabjot; Nesline, Mary Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 65 PD-L1 by RNA next generation sequencing: comparison with PD-L1 IHC 22C3 and association with survival benefit from pembrolizumab with or without chemotherapy in non-small cell lung cancer. (9th November 2020) Authors: Lee, Yong Hee; Dy, Grace; DePietro, Paul; Conroy, Jeffrey; Pabla, Sarabjot; Nesline, Mary Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Critical acral ischaemia leading to multiple finger amputation: side‐effect of long‐term (>30 cycles) pemetrexed maintenance treatment in a patient. (November 2014) Authors: Gupta, Neha; Gupta, Sahil; Gandhi, Shipra; Hatoum, Hassan; Dy, Grace Journal: British journal of clinical pharmacology Issue: Volume 78:Number 5(2014:Nov.) Page Start: 1167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Role of Private Enterprise in Cancer Control in Low to Middle Income Countries. (13th December 2016) Authors: Nwogu, Chukwumere E.; Mahoney, Martin; Okoye, Ifeoma; Ejiogu, Kenneth; George, Saby; Dy, Grace; Jimoh, Mutiu; Salako, Omolola; Ilegbune, Oge; Chugani, Bindiya; Ezeome, Emmanuel; Popoola, Abiodun O.; Michalek, Arthur M. Other Names: Dey Subhojit Academic Editor. Journal: Journal of cancer epidemiology Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗